- Easy Tracking In The Watchlist
Big movements in Virax Biolabs Group Limited stock price on Monday moving 17.52% between high and low
(Updated on Jun 29, 2026)
The Virax Biolabs Group Limited stock price gained 4.82% on the last trading day (Monday, 29th Jun 2026), rising from $3.11 to $3.26. During the last trading day the stock fluctuated 17.52% from a day low at $3.14 to a day high of $3.69. The price has fallen in 6 of the last 10 days and is down by -29.13% for this period. Volume fell on the last day by -273 thousand shares and in total, 403 thousand shares were bought and sold for approximately $1.31 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.12 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 11.60% during the next 3 months and, with a 90% probability hold a price between $3.49 and $9.31 at the end of this 3-month period.
VRAX Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, June 26, 2026, and so far it has risen 4.82%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Virax Biolabs Group Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.62 and $4.78. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Virax Biolabs Group Limited stock
Virax Biolabs Group Limited finds support from accumulated volume at $3.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.550 between high and low, or 17.52%. For the last week the stock has had daily average volatility of 25.20%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (VRAX) For The Upcoming Trading Day Of Tuesday 30th
For the upcoming trading day on Tuesday, 30th we expect Virax Biolabs Group Limited to open at $3.36, and during the day (based on 14 day Average True Range), to move between $2.84 and $3.68, which gives a possible trading interval of +/-$0.85 (+/-29.87%) up or down from last closing price. If Virax Biolabs Group Limited takes out the full calculated possible swing range there will be an estimated 29.87% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $3.15 (3.37%) than the resistance at $3.70 (13.50%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Virax Biolabs Group Limited stock A Buy?
The Virax Biolabs Group Limited stock holds several negative signals and despite the positive trend, we believe Virax Biolabs Group Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score:
-1.184
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 30, 2026 - $3.36 ( 3.17%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
VRAX Performance
Trading levels for VRAX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.91 | 20.04% |
| R2 | 3.70 | 13.60% |
| R1 | 3.57 | 9.61% |
| Price | 3.26 | |
| S1 | 3.15 | -3.28% |
| S2 | 3.02 | -7.26% |
| S3 | 2.81 | -13.70% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.75 | 15.03% |
| R2 | 3.73 | 14.34% |
| R1 | 3.70 | 13.50% |
| Price | 3.26 | |
| S1 | 3.15 | -3.37% |
| S2 | 3.11 | -4.60% |
| S3 | 2.60 | -20.17% |
FAQ
Click here for our free guide on how to buy Virax Biolabs Group Limited Stock.
Buy VRAX